Xeris Biopharma Holdings XERS
NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST

Xeris Biopharma Holdings (XERS) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Xeris Biopharma Holdings (XERS) recorded Return on Capital Employed [ROCE] of 17.23% in Q2 2026, up 21.50 percentage points from -4.27% a year earlier and up 3.89 percentage points from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Xeris Biopharma Holdings reported Return on Capital Employed [ROCE] of 10.22%, up 25.34 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for four straight years, with a four-year change of +85.62 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -15.13% in FY2024 (+3.33 pp), -18.46% in FY2023 (+14.21 pp), -32.67% in FY2022 (+42.74 pp) and -75.41% in FY2021.
  • The Q2 2026 figure is the highest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2021.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for 15 consecutive quarters, with an average year-over-year change of +14.44 percentage points over the last eight quarters.
  • The year-over-year gain in Return on Capital Employed [ROCE] has ranged between 1.27 percentage points (Q3 2024) and 50.23 percentage points (Q4 2022) over the last five years.
  • Per Business Quant, the preceding three quarters came in at 13.34% (Q1 2026), 9.31% (Q4 2025) and 4.15% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Xeris Biopharma Holdings 2.89 Bn 2.41 Bn 94.80 Mn 16.53%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 16.53%
Jun 30, 2026 17.23%
Mar 31, 2026 13.34%
Dec 31, 2025 9.31%
Sep 30, 2025 4.15%
Jun 30, 2025 -4.27%
Mar 31, 2025 -10.03%
Dec 31, 2024 -15.18%
Sep 30, 2024 -19.19%
Jun 30, 2024 -14.37%
Mar 31, 2024 -17.53%
Dec 31, 2023 -19.13%
Sep 30, 2023 -20.45%
Jun 30, 2023 -25.76%
Mar 31, 2023 -26.30%
Dec 31, 2022 -32.76%
Sep 30, 2022 -47.49%
Jun 30, 2022 -45.76%
Mar 31, 2022 -50.09%
Dec 31, 2021 -82.98%
API Access

Xeris Biopharma Holdings Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XERS&period=max&api_key=YOUR_API_KEY